Crossmark Global Holdings’s Abbott ABT Stock Holding History

Crossmark Global Holdings’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.2M	Buy	321,847 +8,763	+3%	+$800K	0.38%	59
2026 Q1	$32.1M	Buy	313,084 +7,867	+3%	+$888K	0.47%	40
2025 Q4	$38.2M	Buy	305,217 +4,444	+1%	+$566K	0.55%	34
2025 Q3	$40.3M	Buy	300,773 +12,373	+4%	+$1.62M	0.6%	21
2025 Q2	$39.2M	Buy	288,400 +15,562	+6%	+$2.05M	0.63%	23
2025 Q1	$36.2M	Sell	272,838 -66,038	-19%	-$8.4M	0.64%	23
2024 Q4	$38.3M	Buy	338,876 +610	+0.2%	+$70.5K	0.7%	20
2024 Q3	$38.6M	Buy	338,266 +5,047	+2%	+$554K	0.69%	19
2024 Q2	$34.6M	Buy	333,219 +1,663	+0.5%	+$176K	0.66%	19
2024 Q1	$37.7M	Sell	331,556 -16,715	-5%	-$1.92M	0.72%	18
2023 Q4	$38.3M	Buy	348,271 +27,527	+9%	+$2.75M	0.8%	14
2023 Q3	$31.3M	Buy	320,744 +128,779	+67%	+$13.5M	0.71%	19
2023 Q2	$21.6M	Sell	191,965 -93,543	-33%	-$9.97M	0.47%	38
2023 Q1	$28.9M	Buy	285,508 +6,270	+2%	+$662K	0.68%	22
2022 Q4	$30.7M	Buy	279,238 +5,391	+2%	+$558K	0.76%	12
2022 Q3	$26.5M	Sell	273,847 -24,629	-8%	-$2.63M	0.74%	15
2022 Q2	$32.4M	Sell	298,476 -4,893	-2%	-$556K	0.84%	10
2022 Q1	$35.9M	Buy	303,369 +4,941	+2%	+$613K	0.8%	11
2021 Q4	$42M	Sell	298,428 -22,230	-7%	-$2.85M	0.91%	13
2021 Q3	$37.9M	Sell	320,658 -21,872	-6%	-$2.69M	0.89%	8
2021 Q2	$39.7M	Buy	342,530 +102,089	+42%	+$11.9M	0.93%	8
2021 Q1	$28.8M	Sell	240,441 -18,173	-7%	-$2.15M	0.71%	18
2020 Q4	$28.3M	Sell	258,614 -114,949	-31%	-$12.5M	0.72%	20
2020 Q3	$40.7M	Sell	373,563 -14,753	-4%	-$1.5M	1.14%	4
2020 Q2	$35.5M	Sell	388,316 -15,622	-4%	-$1.41M	1.04%	6
2020 Q1	$31.9M	Buy	403,938 +97,646	+32%	+$8.15M	1.14%	5
2019 Q4	$26.6M	Sell	306,292 -6,512	-2%	-$545K	0.73%	14
2019 Q3	$26.2M	Buy	312,804 +6,975	+2%	+$593K	0.76%	16
2019 Q2	$25.7M	Sell	305,829 -7,412	-2%	-$583K	0.72%	18
2019 Q1	$25M	Sell	313,241 -32,390	-9%	-$2.41M	0.71%	17
2018 Q4	$25M	Sell	345,631 -7,630	-2%	-$536K	0.77%	14
2018 Q3	$25.9M	Sell	353,261 -18,271	-5%	-$1.2M	0.66%	17
2018 Q2	$22.7M	Sell	371,532 -1,518	-0.4%	-$92K	0.61%	23
2018 Q1	$22.4M	Sell	373,050 -7,480	-2%	-$451K	0.58%	26
2017 Q4	$21.7M	Sell	380,530 -10,836	-3%	-$601K	0.52%	28
2017 Q3	$20.9M	Buy	+391,366	New	+$19.6M	0.54%	29
2016 Q3	$20.9M	Buy	+391,366	New	+$16.8M	0.54%	29

Other funds holding ABT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Crossmark Global Holdings's ABT Position: Q2 2026 in Review

Crossmark Global Holdings increased its Abbott (ABT) stake by 2.8% in Q2 2026, buying an estimated $800K and bringing the position to 321,847 shares worth $29.2M. The position accounts for 0.38% of the portfolio, ranked #59.

Crossmark Global Holdings first reported a position in ABT in Q3 2016 and has held it in 37 quarters since. The position peaked at $42M in Q4 2021. 685 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Crossmark Global Holdings held 321,847 shares of Abbott worth $29.2M as of Q2 2026.
Crossmark Global Holdings bought 8,763 Abbott shares in Q2 2026, an estimated $800K.
Abbott made up 0.38% of Crossmark Global Holdings's portfolio in Q2 2026, its #59 holding.
Crossmark Global Holdings first reported a position in Abbott in Q3 2016 and has held it in 37 quarters since.
Crossmark Global Holdings's Abbott position peaked at $42M in Q4 2021.
685 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.